中国骨质疏松杂志
中國骨質疏鬆雜誌
중국골질소송잡지
CHINESE JOURNAL OF OSTEOPOROSIS
2014年
8期
943-947
,共5页
林丽萍%席建红%李英%吕晔
林麗萍%席建紅%李英%呂曄
림려평%석건홍%리영%려엽
氨基葡萄糖%硫酸软骨素%协同作用%骨质疏松
氨基葡萄糖%硫痠軟骨素%協同作用%骨質疏鬆
안기포도당%류산연골소%협동작용%골질소송
Glucosamine hydrochlorid%Chondroitin sulfate%Synergic effect%Osteoporosis
目的:评价氨基葡萄糖和硫酸软骨素在预防和治疗骨质疏松方面的协同作用。方法通过测定Wistar大鼠的体重、股骨重量、骨密度以及骨钙含量,并与单独饲喂碳酸钙组(阳性对照组)进行对照。饲喂的剂量分别相当于人体推荐剂量的5倍( GHC-5组,每日250 mg/kg?BW),10倍( GHC-10组剂量,每日500 mg/kg?BW)和30倍( GHC-30组,每日1500 mg/kg?BW)。然后分别测定并比较给药组、阳性对照和阴性对照的股骨重,骨矿物质密度( BMD)和钙的含量(钙%)。各组均喂低钙基础饲料(0.15%),自由饮用去离子水。碳酸钙对照组的每日食用钙含量与高剂量组相同,即203mg/kg?BW,低钙对照组以等体积的去离子水代替受试物溶液灌胃。结果实验12周后,GHC-10组的股骨重量、骨密度和骨钙含量与阴性对照组相比有显著提高,而GHC-30组的3个测试指标比阳性对照组显著增加。结论实验结果以及文献报道均表明盐酸氨基葡萄糖和硫酸软骨素对人类的骨质疏松症治疗具有协同效益。
目的:評價氨基葡萄糖和硫痠軟骨素在預防和治療骨質疏鬆方麵的協同作用。方法通過測定Wistar大鼠的體重、股骨重量、骨密度以及骨鈣含量,併與單獨飼餵碳痠鈣組(暘性對照組)進行對照。飼餵的劑量分彆相噹于人體推薦劑量的5倍( GHC-5組,每日250 mg/kg?BW),10倍( GHC-10組劑量,每日500 mg/kg?BW)和30倍( GHC-30組,每日1500 mg/kg?BW)。然後分彆測定併比較給藥組、暘性對照和陰性對照的股骨重,骨礦物質密度( BMD)和鈣的含量(鈣%)。各組均餵低鈣基礎飼料(0.15%),自由飲用去離子水。碳痠鈣對照組的每日食用鈣含量與高劑量組相同,即203mg/kg?BW,低鈣對照組以等體積的去離子水代替受試物溶液灌胃。結果實驗12週後,GHC-10組的股骨重量、骨密度和骨鈣含量與陰性對照組相比有顯著提高,而GHC-30組的3箇測試指標比暘性對照組顯著增加。結論實驗結果以及文獻報道均錶明鹽痠氨基葡萄糖和硫痠軟骨素對人類的骨質疏鬆癥治療具有協同效益。
목적:평개안기포도당화류산연골소재예방화치료골질소송방면적협동작용。방법통과측정Wistar대서적체중、고골중량、골밀도이급골개함량,병여단독사위탄산개조(양성대조조)진행대조。사위적제량분별상당우인체추천제량적5배( GHC-5조,매일250 mg/kg?BW),10배( GHC-10조제량,매일500 mg/kg?BW)화30배( GHC-30조,매일1500 mg/kg?BW)。연후분별측정병비교급약조、양성대조화음성대조적고골중,골광물질밀도( BMD)화개적함량(개%)。각조균위저개기출사료(0.15%),자유음용거리자수。탄산개대조조적매일식용개함량여고제량조상동,즉203mg/kg?BW,저개대조조이등체적적거리자수대체수시물용액관위。결과실험12주후,GHC-10조적고골중량、골밀도화골개함량여음성대조조상비유현저제고,이GHC-30조적3개측시지표비양성대조조현저증가。결론실험결과이급문헌보도균표명염산안기포도당화류산연골소대인류적골질소송증치료구유협동효익。
Objective To investigate the synergic effect of glucosamine hydrochlorid and chondroitin sulfate ( GHC ) in the prevention and treatment of osteoporosis.Methods The body weights ( BWs ) , the femur weights, the bone mineral density ( BMD) , and the calcium content ( Ca%) of the femur of the Wistar rats were determined.All the data were compared with those in calcium carbonate alone treated group ( positive control ) . The dosage used was the amount equal to the 5-fold higher recommended supplements for humans (GHC-5 group, 250 mg/kg per day), 10-fold higher (GHC-10 group, 500 mg/kg per day), and 30-fold higher (GHC-30 group, 1500 mg/kg per day).Rats in each group were fed with a low-calcium diet (0.15%Ca) and deionized water with GHC (GHC-5, GHC-10, GHC-30) or without GHC (negative control and positive control, the amount of dietary calcium was equal to GHC-30 group, 203 mg/kg).Results After 12-week treatment, the femur weight, BMD, and the femur Ca%in GHC-10 group increased significantly compared with those in negative control group.However the results of GHC-30 group were higher than those in positive group.Conclusion The present observation concurrents with earlier reports showing the synergic effect of GHC in the treatment of osteoporosis for human beings.